[taylor&francis] Bioanalytical challenges and solutions for immunogenicity evaluation of bispecific antibody therapeutics |
10
A patent review of CYP3A4 inhibitors (2018 – present)
10
Phase II basket study of brigatinib for ALK fusion-positive solid tumors: WJOG15221M/ALLBREAK (a decentralized clinical trial design)
10
Protests in the United States on Palestine and Israel, 2023–2024
10
The embeddedness of unions in collective action fields: ‘organizational’ vs ‘social movement’ unionism
10
Interpretive bridges: language difference as an opportunity for ally mobilization in the Campaign for Fair Food